Targeting the mTOR pathway for T cell modulation has shown promise in autoimmune diseases and cancer therapy, with studies demonstrating that mTOR inhibition can mitigate SAI, reduce organ damage, and improve sepsis outcomes (15–17). Here, MTOR is linked to autoimmune disease.